A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens.


Journal

Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028

Informations de publication

Date de publication:
12 2019
Historique:
received: 09 11 2018
revised: 29 04 2019
accepted: 01 05 2019
pubmed: 23 6 2019
medline: 10 9 2020
entrez: 23 6 2019
Statut: ppublish

Résumé

In the house dust mite (HDM) Dermatophagoides pteronyssinus, Der p 1, 2, 5, 7, 21, and 23 have been identified as the most important allergens. The aim of this study was to define hypoallergenic peptides derived from the sequences of the six allergens and to use the peptides and the complete allergens to study antibody, T cell, and cytokine responses in sensitized and nonsensitized subjects. IgE reactivity of HDM-allergic and non-HDM-sensitized individuals to 15 HDM allergens was established using ImmunoCAP ISAC technology. Thirty-three peptides covering the sequences of the six HDM allergens were synthesized. Allergens and peptides were tested for IgE and IgG reactivity by ELISA and ImmunoCAP, respectively. Allergenic activity was determined by basophil activation. CD4+ T cell and cytokine responses were determined in PBMC cultures by CFSE dilution and Luminex technology, respectively. House dust mite allergics showed IgE reactivity only to complete allergens, whereas 31 of the 33 peptides lacked relevant IgE reactivity and allergenic activity. IgG antibodies of HDM-allergic and nonsensitized subjects were directed against peptide epitopes and higher allergen-specific IgG levels were found in HDM allergics. PBMC from HDM-allergics produced higher levels of IL-5 whereas non-HDM-sensitized individuals mounted higher levels of IFN-gamma, IL-17, pro-inflammatory cytokines, and IL-10. IgG antibodies in HDM-allergic patients recognize peptide epitopes which are different from the epitopes recognized by IgE. This may explain why naturally occurring allergen-specific IgG antibodies do not protect against IgE-mediated allergic inflammation. A mix of hypoallergenic peptides containing T cell epitopes of the most important HDM allergens was identified.

Sections du résumé

BACKGROUND
In the house dust mite (HDM) Dermatophagoides pteronyssinus, Der p 1, 2, 5, 7, 21, and 23 have been identified as the most important allergens. The aim of this study was to define hypoallergenic peptides derived from the sequences of the six allergens and to use the peptides and the complete allergens to study antibody, T cell, and cytokine responses in sensitized and nonsensitized subjects.
METHODS
IgE reactivity of HDM-allergic and non-HDM-sensitized individuals to 15 HDM allergens was established using ImmunoCAP ISAC technology. Thirty-three peptides covering the sequences of the six HDM allergens were synthesized. Allergens and peptides were tested for IgE and IgG reactivity by ELISA and ImmunoCAP, respectively. Allergenic activity was determined by basophil activation. CD4+ T cell and cytokine responses were determined in PBMC cultures by CFSE dilution and Luminex technology, respectively.
RESULTS
House dust mite allergics showed IgE reactivity only to complete allergens, whereas 31 of the 33 peptides lacked relevant IgE reactivity and allergenic activity. IgG antibodies of HDM-allergic and nonsensitized subjects were directed against peptide epitopes and higher allergen-specific IgG levels were found in HDM allergics. PBMC from HDM-allergics produced higher levels of IL-5 whereas non-HDM-sensitized individuals mounted higher levels of IFN-gamma, IL-17, pro-inflammatory cytokines, and IL-10.
CONCLUSION
IgG antibodies in HDM-allergic patients recognize peptide epitopes which are different from the epitopes recognized by IgE. This may explain why naturally occurring allergen-specific IgG antibodies do not protect against IgE-mediated allergic inflammation. A mix of hypoallergenic peptides containing T cell epitopes of the most important HDM allergens was identified.

Identifiants

pubmed: 31228873
doi: 10.1111/all.13956
pmc: PMC7078969
doi:

Substances chimiques

Allergens 0
Antigens, Dermatophagoides 0
Arthropod Proteins 0
Cytokines 0
Epitopes, T-Lymphocyte 0
Immunoglobulin G 0
Peptides 0
Immunoglobulin E 37341-29-0
Cysteine Endopeptidases EC 3.4.22.-
Dermatophagoides pteronyssinus antigen p 1 EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2461-2478

Subventions

Organisme : Austrian Science Fund FWF
ID : F 4605
Pays : Austria
Organisme : Austrian Science Fund (FWF)
ID : F4602
Pays : International
Organisme : Megagrant of the Government of the Russian Federation
ID : 14.W03.31.0024
Pays : International
Organisme : Austrian Science Fund (FWF)
ID : DK W 1248-B30
Pays : International
Organisme : Austrian Science Fund (FWF)
ID : F4605
Pays : International
Organisme : Medizinische Universität Wien
Pays : International
Organisme : Austrian Science Fund FWF
ID : P 29991
Pays : Austria

Informations de copyright

© 2019 The Authors. Allergy Published by John Wiley & Sons Ltd.

Références

Clin Exp Allergy. 2002 Oct;32(10):1461-7
pubmed: 12372126
J Allergy Clin Immunol. 2016 Feb;137(2):351-7
pubmed: 26853127
J Allergy Clin Immunol. 2017 Feb;139(2):541-549.e8
pubmed: 27793411
J Allergy Clin Immunol. 2013 Jan;131(1):103-9.e1-7
pubmed: 22981787
EBioMedicine. 2018 May;31:66-78
pubmed: 29678672
Sci Rep. 2017 Sep 14;7(1):11657
pubmed: 28912492
J Allergy Clin Immunol. 1994 Mar;93(3):628-34
pubmed: 7512103
J Allergy Clin Immunol. 2018 Aug;142(2):398-400
pubmed: 29906529
Allergy. 2019 Dec;74(12):2461-2478
pubmed: 31228873
Nat Rev Immunol. 2012 Oct;12(10):721-8
pubmed: 22955843
Lancet. 2005 Jan 8-14;365(9454):142-9
pubmed: 15639296
J Allergy Clin Immunol. 2016 Oct;138(4):984-1010
pubmed: 27577879
Curr Allergy Asthma Rep. 2018 Jun 9;18(7):39
pubmed: 29886521
Clin Exp Allergy. 2015 Oct;45(10):1601-12
pubmed: 25652035
Drug Discov Today. 2015 Jan;20(1):122-8
pubmed: 25450771
J Allergy Clin Immunol. 2017 Dec;140(6):1485-1498
pubmed: 29221580
J Allergy Clin Immunol. 1994 May;93(5):891-9
pubmed: 7514196
J Allergy Clin Immunol. 2006 Aug;118(2):361-7
pubmed: 16890759
Curr Top Microbiol Immunol. 2011;352:107-19
pubmed: 21567311
J Allergy Clin Immunol. 2018 Oct;142(4):1322-1330
pubmed: 29428391
Allergy. 2015 Oct;70(10):1222-9
pubmed: 26043182
J Allergy Clin Immunol. 2015 Oct;136(4):1083-91
pubmed: 25956509
J Immunol. 1993 Apr 15;150(8 Pt 1):3643-50
pubmed: 8468493
Adv Immunol. 2018;138:195-256
pubmed: 29731005
Curr Allergy Asthma Rep. 2016 Feb;16(2):14
pubmed: 26768622
Semin Immunol. 2017 Apr;30:67-80
pubmed: 28939389
Immunol Lett. 2017 Sep;189:19-26
pubmed: 28472641
Eur J Clin Invest. 2008 Dec;38(12):959-65
pubmed: 19021722
Eur Respir J. 1995 Mar;8(3):483-91
pubmed: 7789502
J Allergy Clin Immunol. 2018 Aug;142(2):497-509.e9
pubmed: 29361332
J Korean Med Sci. 2013 Jan;28(1):74-9
pubmed: 23341715
J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):1845-1855.e2
pubmed: 30297269
Int Arch Allergy Appl Immunol. 1990;91(2):124-9
pubmed: 2187817
Chem Immunol Allergy. 2014;100:234-42
pubmed: 24925403
J Allergy Clin Immunol. 2017 Feb;139(2):388-399
pubmed: 28183433
J Immunol. 1992 Feb 1;148(3):738-45
pubmed: 1370514
Pediatr Allergy Immunol. 2016 May;27 Suppl 23:1-250
pubmed: 27288833
Mol Immunol. 2018 Aug;100:120-125
pubmed: 29602574
Clin Exp Allergy. 2000 Jul;30(7):934-43
pubmed: 10848915
Adv Exp Med Biol. 1994;347:11-6
pubmed: 7526633
EBioMedicine. 2016 Sep;11:43-57
pubmed: 27650868
Allergy. 1998;53(48 Suppl):108-14
pubmed: 10096821
J Allergy Clin Immunol. 2002 Jul;110(1):102-9
pubmed: 12110828
J Allergy Clin Immunol. 2005 Feb;115(2):399-404
pubmed: 15696102
J Immunol. 1993 Aug 15;151(4):2326-35
pubmed: 7688399
Methods. 2014 Mar 1;66(1):106-19
pubmed: 24161540
Clin Transl Allergy. 2018 Jun 4;8:19
pubmed: 29881542
Immunol Today. 1994 Feb;15(2):91
pubmed: 7512343
Expert Rev Clin Immunol. 2017 Apr;13(4):297-299
pubmed: 28162009
World Allergy Organ J. 2017 Apr 18;10(1):14
pubmed: 28451053
J Allergy Clin Immunol. 2018 Nov;142(5):1656-1659.e9
pubmed: 30059698
J Allergy Clin Immunol. 2011 Jan;127(1):89-97, 97.e1-14
pubmed: 21211644

Auteurs

Huey-Jy Huang (HJ)

Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Mirela Curin (M)

Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Srinita Banerjee (S)

Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Kuan-Wei Chen (KW)

Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Tetiana Garmatiuk (T)

Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Yvonne Resch-Marat (Y)

Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Claudia Carvalho-Queiroz (C)

Department of Clinical Neuroscience, Therapeutic Immune Design Unit, Karolinska Institutet, Stockholm, Sweden.

Katharina Blatt (K)

Division of Hematology&Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

Guro Gafvelin (G)

Department of Clinical Neuroscience, Therapeutic Immune Design Unit, Karolinska Institutet, Stockholm, Sweden.

Hans Grönlund (H)

Department of Clinical Neuroscience, Therapeutic Immune Design Unit, Karolinska Institutet, Stockholm, Sweden.

Peter Valent (P)

Division of Hematology&Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

Raffaela Campana (R)

Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Margarete Focke-Tejkl (M)

Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Rudolf Valenta (R)

Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
NRC Institute of Immunology FMBA of Russia, Moscow, Russia.
Department of Clinical Immunology and Allergy, Laboratory for Immunopathology, Sechenov First Moscow State Medical University, Moscow, Russia.

Susanne Vrtala (S)

Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH